Morgan Stanley (NYSE:MS) has adjusted its stock rating to “Underweight,” reflecting a cautious near-term outlook.
The investment banking industry, where Morgan Stanley is a major player, is expected to grow significantly by 2033.
Despite long-term growth prospects, near-term market volatility, influenced by proposed tariffs, impacts firms like Morgan Stanley.
Morgan Stanley (NYSE:MS) is a leading global financial services firm that provides investment banking, securities, wealth management, and investment management services. On May 16, 2025, Morgan Stanley adjusted its own stock rating to “Underweight,” with the stock price at $132.33, as reported by Benzinga. This decision reflects a cautious outlook on the stock’s near-term performance.
Morgan Stanley, along with JPMorgan, is a major player in the investment banking industry. Both firms are integral to global finance, advising on multibillion-dollar mergers and underwriting high-profile IPOs. The investment banking market is expected to grow significantly, from $170 billion in 2023 to $394.2 billion by 2033, according to Spherical Insights & Consulting.
Despite the promising long-term growth in investment banking, the near-term momentum has slowed. The year 2025 began with optimism due to expectations of a business-friendly Trump administration. However, proposed tariffs have introduced market volatility, impacting the immediate landscape for firms like Morgan Stanley.
Currently, Morgan Stanley’s stock price is $132.44, reflecting a slight decrease of $0.07, or approximately -0.05%. The stock has traded between $131.79 and $132.66 today. Over the past year, it has seen a high of $142.03 and a low of $90.94, with a market capitalization of approximately $212.48 billion.
Today’s trading volume for Morgan Stanley is 1,473,632 shares on the NYSE. Despite the recent “Underweight” rating, the firm remains a key player in the investment banking sector, poised to benefit from the projected market growth over the next decade.
